Your session is about to expire
← Back to Search
VR Technology for Pupil Disorders (RAPD Trial)
N/A
Recruiting
Led By Kevin H Merkley, MD, MBA
Research Sponsored by The University of Texas Medical Branch, Galveston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18 - 85
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately following the swinging light test or vr hmd light test
Awards & highlights
RAPD Trial Summary
This trial will test if an off-the-shelf virtual reality headset and machine learning algorithms can accurately detect a common eye disorder.
Who is the study for?
This trial is for UTMB clinic patients aged 18-85 with known Relative Afferent Pupillary Defect (RAPD) or vision disorders like glaucoma. It's not for those outside this age range, non-English speakers, people uncomfortable with VR devices or glasses, and those with congenital pupil issues.Check my eligibility
What is being tested?
Researchers are testing if a virtual reality headset combined with machine learning can detect RAPD more reliably and earlier than the standard swinging flashlight test. Participants will undergo both methods to compare effectiveness.See study design
What are the potential side effects?
There may be discomfort from using the VR head-mounted display, especially for individuals who typically experience discomfort when using glasses or similar devices.
RAPD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 85 years old.
RAPD Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately following the swinging light test or vr hmd light test
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately following the swinging light test or vr hmd light test
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Pupillary measurements
RAPD Trial Design
2Treatment groups
Experimental Treatment
Group I: No Known RAPDExperimental Treatment2 Interventions
Participants with no known RAPD will be administered the standard of care swinging light test and pupil measurements taken manually, then administered the light test using the VR HMD and ML.
Group II: Known RAPDExperimental Treatment2 Interventions
Participants with known RAPD will be administered the standard of care swinging light test and pupil measurements taken manually, then administered the light test using the VR HMD and ML.
Find a Location
Who is running the clinical trial?
The University of Texas Medical Branch, GalvestonLead Sponsor
243 Previous Clinical Trials
56,551 Total Patients Enrolled
University of Nevada, RenoOTHER
30 Previous Clinical Trials
18,644 Total Patients Enrolled
Kevin H Merkley, MD, MBAPrincipal InvestigatorUniversity of Texas
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I speak English to avoid misunderstandings during consent.You have a history of pupils being abnormal due to birth or injury.You have trouble wearing glasses.This criterion refers to the exclusion of 60 patients with known Relative Afferent Pupillary Defect (RAPD).You feel uncomfortable when using a VR headset.I have been diagnosed with a vision disorder like glaucoma or diabetic retinopathy.I am younger than 18 or older than 85.I am between 18 and 85 years old.They are looking for 60 patients who do not have a known relative afferent pupillary defect (RAPD).
Research Study Groups:
This trial has the following groups:- Group 1: No Known RAPD
- Group 2: Known RAPD
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are individuals aged 40 and over being solicited for participation in this research?
"This clinical trial is inviting all individuals 18 years of age or older and not exceeding 85 years old to join."
Answered by AI
Who is most suitable for enrollment in this trial?
"Eligibility for this clinical trial necessitates a diagnosis of relative afferent pupil defect (RAPD) and being in the age bracket between 18-85 years old. A total of 120 participants are required to partake in the study."
Answered by AI
Are there any opportunities available to participate in this investigation?
"This research program, which was initially advertised on May 4th 2023 and most recently modified the following day, is actively seeking participants."
Answered by AI
How many participants can be included in this clinical trial?
"Affirmative. Digital information hosted on clinicaltrials.gov demonstrate that this medical trial, first listed on May 4th 2023, is recruiting participants at present. A total of 120 individuals are required for the research to be conducted across a single facility."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger